Show simple item record

dc.contributor.authorBrowning, L
dc.contributor.authorColling, R
dc.contributor.authorRakha, E
dc.contributor.authorRajpoot, N
dc.contributor.authorRittscher, J
dc.contributor.authorJames, JA
dc.contributor.authorSalto-Tellez, M
dc.contributor.authorSnead, DRJ
dc.contributor.authorVerrill, C
dc.date.accessioned2020-08-27T09:11:32Z
dc.date.issued2020-07-03
dc.identifier.citationJournal of clinical pathology, 2020
dc.identifier.issn0021-9746
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/4033
dc.identifier.eissn1472-4146
dc.identifier.doi10.1136/jclinpath-2020-206854
dc.description.abstractThe measures to control the COVID-19 outbreak will likely remain a feature of our working lives until a suitable vaccine or treatment is found. The pandemic has had a substantial impact on clinical services, including cancer pathways. Pathologists are working remotely in many circumstances to protect themselves, colleagues, family members and the delivery of clinical services. The effects of COVID-19 on research and clinical trials have also been significant with changes to protocols, suspensions of studies and redeployment of resources to COVID-19. In this article, we explore the specific impact of COVID-19 on clinical and academic pathology and explore how digital pathology and artificial intelligence can play a key role to safeguarding clinical services and pathology-based research in the current climate and in the future.
dc.formatPrint-Electronic
dc.languageeng
dc.language.isoeng
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.titleDigital pathology and artificial intelligence will be key to supporting clinical and academic cellular pathology through COVID-19 and future crises: the PathLAKE consortium perspective.
dc.typeJournal Article
dcterms.dateAccepted2020-06-15
rioxxterms.versionofrecord10.1136/jclinpath-2020-206854
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.licenseref.startdate2020-07-03
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfJournal of clinical pathology
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Integrated Pathology
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Integrated Pathology
pubs.publication-statusPublished
pubs.embargo.termsNot known
icr.researchteamIntegrated Pathologyen_US
dc.contributor.icrauthorSalto-Tellez, Manuelen


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0